<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report" xml:lang="en">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Infect Dis</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Infect. Dis</journal-id>
      <journal-title-group>
        <journal-title>BMC Infectious Diseases</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1471-2334</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24004824</article-id>
      <article-id pub-id-type="pmc">3766243</article-id>
      <article-id pub-id-type="publisher-id">1471-2334-13-406</article-id>
      <article-id pub-id-type="doi">10.1186/1471-2334-13-406</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title><italic>Chromobacterium haemolyticum</italic>-induced bacteremia in a healthy young man</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" id="A1">
          <name>
            <surname>Okada</surname>
            <given-names>Megumi</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>megumi2324@yahoo.co.jp</email>
        </contrib>
        <contrib contrib-type="author" corresp="yes" id="A2">
          <name>
            <surname>Inokuchi</surname>
            <given-names>Ryota</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>inokuchir-icu@h.u-tokyo.ac.jp</email>
        </contrib>
        <contrib contrib-type="author" id="A3">
          <name>
            <surname>Shinohara</surname>
            <given-names>Kazuaki</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>k-shinohara@ohta-hp.or.jp</email>
        </contrib>
        <contrib contrib-type="author" id="A4">
          <name>
            <surname>Matsumoto</surname>
            <given-names>Akinori</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>shoken@ohta-hp.or.jp</email>
        </contrib>
        <contrib contrib-type="author" id="A5">
          <name>
            <surname>Ono</surname>
            <given-names>Yuko</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>windmill@fmu.ac.jp</email>
        </contrib>
        <contrib contrib-type="author" id="A6">
          <name>
            <surname>Narita</surname>
            <given-names>Masashi</given-names>
          </name>
          <xref ref-type="aff" rid="I4">4</xref>
          <email>masashi.narita@gmail.com</email>
        </contrib>
        <contrib contrib-type="author" id="A7">
          <name>
            <surname>Ishida</surname>
            <given-names>Tokiya</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>toki007-lightning@poem.ocn.ne.jp</email>
        </contrib>
        <contrib contrib-type="author" id="A8">
          <name>
            <surname>Kazuki</surname>
            <given-names>Chiba</given-names>
          </name>
          <xref ref-type="aff" rid="I5">5</xref>
          <email>chiba_kazuki_01@pref.fukushima.lg.jp</email>
        </contrib>
        <contrib contrib-type="author" id="A9">
          <name>
            <surname>Nakajima</surname>
            <given-names>Susumu</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>nakajimas-ort@h.u-tokyo.ac.jp</email>
        </contrib>
        <contrib contrib-type="author" id="A10">
          <name>
            <surname>Yahagi</surname>
            <given-names>Naoki</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>yahagin-eme@h.u-tokyo.ac.jp</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Department of Emergency and Critical Care Medicine, Ohta Nishinouchi Hospital, 2-5-20 Nishinouchi, 963-8558 Koriyama, Fukushima, Japan</aff>
      <aff id="I2"><label>2</label>Department of Emergency and Critical Care Medicine, The University of Tokyo Hospital, 7-3-1 Hongo, 113-8655 Bunkyo-ku, Tokyo, Japan</aff>
      <aff id="I3"><label>3</label>Department of Emergency and Critical Care Medical Center, Fukushima Medical University Hospital, 1 Hikariga-oka, 960-1295 Fukushima City, Japan</aff>
      <aff id="I4"><label>4</label>Department of Medicine, Ohta Nishinouchi Hospital, 2-5-20 Nishinouchi, 963-8558 Koriyama, Fukushima, Japan</aff>
      <aff id="I5"><label>5</label>Department of Bacteriology, Fukushima Institute of Public Health, 16-6 Mitouchi, Houkida, Fukushima city, Fukushima, Japan</aff>
      <pub-date pub-type="collection">
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>3</day>
        <month>9</month>
        <year>2013</year>
      </pub-date>
      <volume>13</volume>
      <fpage>406</fpage>
      <lpage>406</lpage>
      <history>
        <date date-type="received">
          <day>3</day>
          <month>4</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>28</day>
          <month>8</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2013 Okada et al.; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2013</copyright-year>
        <copyright-holder>Okada et al.; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://www.biomedcentral.com/1471-2334/13/406"/>
      <abstract>
        <sec>
          <title>Background</title>
          <p>The genus <italic>Chromobacterium</italic> consists of 7 recognized species. Among those, only <italic>C. violaceum,</italic> commonly found in the soil and water of tropical and subtropical regions, has been shown to cause human infection. Although human infection is rare, <italic>C. violaceum</italic> can cause life-threatening sepsis, with metastatic abscesses, most frequently infecting those who are young and healthy.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>We recently identified a case of severe bacteremia caused by <italic>Chromobacterium haemolyticum</italic> infection in a healthy young patient following trauma and exposure to river water, in Japan. The patient developed necrotizing fasciitis that was successfully treated with a fasciotomy and intravenous ciprofloxacin and gentamicin.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p><italic>C. haemolyticum</italic> should be considered in the differential diagnosis of skin lesions that progressively worsen after trauma involving exposure to river or lake water, even in temperate regions. Second, early blood cultures for the isolation and identification of the causative organism were important for initiating proper antimicrobial therapy.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>Chromobacterium <italic>haemolyticum</italic></kwd>
        <kwd>Chromobacterium violaceum</kwd>
        <kwd>Sepsis</kwd>
        <kwd>Cellulitis</kwd>
        <kwd>Necrotizing fasciitis</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>The genus <italic>Chromobacterium</italic> consists of 7 recognized species: <italic>C. violaceum</italic>, <italic>C. subtsugae</italic>, <italic>C. aquaticum</italic>, <italic>C. haemolyticum</italic>, <italic>C. pseudoviolaceum</italic>, <italic>C. piscinae</italic>[<xref ref-type="bibr" rid="B1">1</xref>], and <italic>C. vaccinii</italic>[<xref ref-type="bibr" rid="B2">2</xref>]. Of these species, only <italic>C. violaceum,</italic> commonly found in the soil and water of tropical and subtropical regions, has been shown to cause human infection. Although human infection is rare, <italic>C. violaceum</italic> can cause life-threatening sepsis, with metastatic abscesses, most frequently infecting those who are young and healthy [<xref ref-type="bibr" rid="B3">3</xref>].</p>
      <p>We describe, here, clinical evidence for another species, <italic>C. haemolyticum</italic>, which caused an infection in a healthy, young patient<italic>.</italic> This bacterium should be considered in the differential diagnosis of skin lesions that quickly worsen after trauma associated with exposure to river or lake water. This is particularly important because of the species&#x2019; resistance to antimicrobials, particularly &#x3B2;-lactams.</p>
    </sec>
    <sec>
      <title>Case presentation</title>
      <p>A healthy, 26-year-old Japanese man was admitted to our hospital with pain in his left shoulder and leg caused by a road accident; he was hit by a car and thrown into a river. The outside air and water temperatures at the time of the injury were 20&#xB0;C. He had no family history of any particular condition.</p>
      <p>Upon admission, his temperature was 36.6&#xB0;C; pulse rate, 66 beats/min; blood pressure, 143/99&#xA0;mmHg; respiratory rate, 15/min; oxygen saturation, 100% (10-L reservoir mask); and Glasgow Coma Scale score, E4V5M6. A physical examination showed only bruising, not open wounds, on the left side of his face and shoulder and tenderness in his left leg. His height, weight, and body mass index were 175&#xA0;cm, 67&#xA0;kg, and 21.9&#xA0;kg/m<sup>2</sup>, respectively. Laboratory tests showed mild inflammation (white blood cell [WBC] count, 13,500/&#x3BC;L; and C-reactive protein [CRP], 0.9&#xA0;mg/L [normal range: &lt; 2.0&#xA0;mg/L]). A radiograph showed fractures of the fibula shaft and scapula.</p>
      <p>On post-admission day 3, the patient exhibited a temperature of 40&#xB0;C, shivering, and redness and pain in his ankle. Intravenous ampicillin/sulbactam (6&#xA0;g/day) and minocycline (200&#xA0;mg/day) were initiated. However, on the fourth day of admission, the antimicrobial drugs were changed to ceftazidime at 4&#xA0;g/day, as 2 sets of blood culture tests revealed gram-negative bacilli. Until then, the redness in his ankle had not expanded. On day 5, the erythematous, warmth and pain spread to his knee joint, and blisters were observed on the upper part of his foot (Figure&#xA0;<xref ref-type="fig" rid="F1">1</xref>). The patient was diagnosed with necrotizing fasciitis and a fasciotomy was conducted. The underlying muscle appeared healthy, and further debridement was avoided. The pathology of the dorsum of his left foot revealed inflamed skin and soft tissue, with necrosis consistent with necrotizing fasciitis. Laboratory tests showed an inflammatory reaction (WBC count, 13,500/&#x3BC;L; CRP, 196.3&#xA0;mg/L), and hyperglycemia (192&#xA0;mg/dL). Thus, the Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) score [<xref ref-type="bibr" rid="B4">4</xref>] was 6 (intermediate risk). The smear from the fasciotomy site and blood culture tests revealed gram-negative bacilli (Figure&#xA0;<xref ref-type="fig" rid="F2">2</xref>A), and the infecting bacterium was oxidase-positive and produced grey colonies, with a 4.3-mm hemolytic zone on sheep blood-agar plates (Figure&#xA0;<xref ref-type="fig" rid="F2">2</xref>B); non-pigmented colonies were found on bromothymol-blue lactose agar plates, suggesting that <italic>C. haemolyticum</italic> was the causative agent. However, the Vitek GNI + card (bioM&#xE9;rieux Vitek, Hazelwood, MO, USA) and the API 20 NE test (bioM&#xE9;rieux Vitek) identified the organism as <italic>C. violaceum</italic>. The antibiotics were changed to intravenous ciprofloxacin (900&#xA0;mg/day) and gentamicin (400&#xA0;mg/day [6&#xA0;mg&#x2009;&#xB7;&#x2009;kg<sup>-1</sup>&#x2009;&#xB7;&#x2009;day<sup>-1</sup>]). This antimicrobial regimen was continued for 28&#xA0;days. After that, gentamicin was discontinued. The trough value of gentamicin was 0.3&#xA0;&#x3BC;g/mL (6.1&#xA0;&#x3BC;mol/L) on days 8, 10, and 18. On day 33, the patient was discharged with a 14-day prescription for oral ciprofloxacin (1600&#xA0;mg/day [25&#xA0;mg&#x2009;&#xB7;&#x2009;kg<sup>-1</sup>&#x2009;&#xB7;&#x2009;day<sup>-1</sup>]). Therefore, this patient was treated with gentamicin for 23&#xA0;days, intravenous ciprofloxacin for 28&#xA0;days, and oral ciprofloxacin for 14&#xA0;days. Subsequently, the identification of the <italic>C. haemolyticum</italic> strain, MDA0585<sup>T</sup>, was confirmed, based on its 16S rRNA gene sequence. Six months after the accident, the patient was free of recurrent infection.</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p><bold>Clinical presentation on day 6.</bold>The patient experienced a burning sensation, tenderness, and redness in his left leg, from the upper part of his foot to his knee. Blisters are shown on the dorsum of the foot.</p>
        </caption>
        <graphic xlink:href="1471-2334-13-406-1"/>
      </fig>
      <fig id="F2" position="float">
        <label>Figure 2</label>
        <caption>
          <p><bold>Microbiological results. A</bold>. A large number of short, tapered, gram-negative bacilli were present in fasciotomy. (Gram stain, &#xD7;400 original magnification). <bold>B</bold>. <italic>Chromobacterium haemolyticum</italic> colonies, showing marked hemolysis on sheep blood agar after a 24-h culture.</p>
        </caption>
        <graphic xlink:href="1471-2334-13-406-2"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>Before the recognition of <italic>C. haemolyticum</italic> in 2011, less than 140 proven cases of human infection with <italic>C. violaceum</italic> had been reported [<xref ref-type="bibr" rid="B3">3</xref>]. Among the few reports of infections caused by non-pigmented, &#x3B2;-hemolytic strains of <italic>C. violaceum</italic>, identification of <italic>C. haemolyticum</italic> strain MDA0585<sup>T</sup> by 16S rRNA gene sequencing has not been previously reported. Thus, we present the first clinical evidence for <italic>C. haemolyticum</italic> infection.</p>
      <p><italic>C. haemolyticum</italic>, strain MDA0585<sup>T</sup>, is a gram-negative bacillus, and has been isolated from a clinical sample [<xref ref-type="bibr" rid="B5">5</xref>] and from lake water [<xref ref-type="bibr" rid="B1">1</xref>]. <italic>C. violaceum</italic> and <italic>C. haemolyticum</italic> are closely related, phylogenetically, making them impossible to distinguish based on results of biochemical tests (i.e., the Vitek GNI + card and the API 20 NE test)<italic>.</italic> However, the lack of violet pigmentation, hemolysis of sheep blood, and positive oxidase test results allow an accurate identification. Hence, as shown in the current report, these features can be used to differentiate between these 2 bacterial species in a clinical setting.</p>
      <p>We have investigated the minimum inhibitory concentration for <italic>C. haemolyticum.</italic> In addition, Han <italic>et al.</italic> showed differences in the antibiotic susceptibility of <italic>C. haemolyticum</italic> and <italic>C. violaceum</italic> in clinical samples; hence, we compared them and the results are shown in Table&#xA0;<xref ref-type="table" rid="T1">1</xref>[<xref ref-type="bibr" rid="B5">5</xref>]<italic>. C. haemolyticum</italic> was more resistant, overall, with higher minimum inhibitory concentrations for most drugs. Thus, the ability to differentiate between these 2 bacterial species is important when infection with <italic>C. haemolyticum</italic> is suspected because of its greater resistance to antimicrobials, especially the &#x3B2;-lactams [<xref ref-type="bibr" rid="B5">5</xref>].</p>
      <table-wrap position="float" id="T1">
        <label>Table 1</label>
        <caption>
          <p>
            <bold>Growth, biochemical reactions, and results of antibiotic susceptibility tests for </bold>
            <bold>
              <italic>C. haemolyticum </italic>
            </bold>
            <bold>isolates</bold>
          </p>
        </caption>
        <table frame="hsides" rules="groups" border="1">
          <colgroup>
            <col align="left"/>
            <col align="center"/>
            <col align="center"/>
            <col align="center"/>
          </colgroup>
          <thead valign="top">
            <tr>
              <th align="left">&#xA0;</th>
              <th align="center">
                <bold>Present case</bold>
              </th>
              <th colspan="2" align="center"><bold>Xan </bold><bold><italic>et al.</italic></bold>[<xref ref-type="bibr" rid="B5">5</xref>]</th>
            </tr>
          </thead>
          <tbody valign="top">
            <tr>
              <td align="left" valign="bottom">Characteristic<hr/></td>
              <td align="center" valign="bottom">
                <italic>C. haemolyticum</italic>
                <hr/>
              </td>
              <td align="center" valign="bottom">
                <italic>C. haemolyticum</italic>
                <hr/>
              </td>
              <td align="center" valign="bottom">
                <italic>C. violaceum</italic>
                <hr/>
              </td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Growth on agar (37&#xB0;C, 5% CO<sub>2</sub>, 24&#xA0;h):<hr/></td>
              <td align="center" valign="bottom">Non-pigmented<hr/></td>
              <td align="center" valign="bottom">Non-pigmented<hr/></td>
              <td align="center" valign="bottom">Purple<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">&#x2003;&#x2009;Sheep blood<hr/></td>
              <td align="center" valign="bottom">2.3&#xA0;mm, &#x3B2;<italic>-</italic>hemolysis<hr/></td>
              <td align="center" valign="bottom">2&#xA0;mm, &#x3B2;<italic>-</italic>hemolysis<hr/></td>
              <td align="center" valign="bottom">2&#xA0;mm, no hemolysis<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">&#x2003;&#x2009;Chocolate<hr/></td>
              <td align="center" valign="bottom">2.9&#xA0;mm<hr/></td>
              <td align="center" valign="bottom">2&#xA0;mm<hr/></td>
              <td align="center" valign="bottom">2&#xA0;mm<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">&#x2003;&#x2009;Buffered charcoal yeast extract<hr/></td>
              <td align="center" valign="bottom">NA<hr/></td>
              <td align="center" valign="bottom">2&#xA0;mm, flat, dull<hr/></td>
              <td align="center" valign="bottom">2&#xA0;mm, raised, shiny<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">&#x2003;&#x2009;Trypticase soy<hr/></td>
              <td align="center" valign="bottom">2.9&#xA0;mm<hr/></td>
              <td align="center" valign="bottom">1.8&#xA0;mm<hr/></td>
              <td align="center" valign="bottom">1&#xA0;mm<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">&#x2003;&#x2009;MacConkey<hr/></td>
              <td align="center" valign="bottom">NA<hr/></td>
              <td align="center" valign="bottom">0.2&#xA0;mm, pinpoint<hr/></td>
              <td align="center" valign="bottom">1&#xA0;mm<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">&#x2003;&#x2009;Hektoen enteric<hr/></td>
              <td align="center" valign="bottom">NA<hr/></td>
              <td align="center" valign="bottom">No growth<hr/></td>
              <td align="center" valign="bottom">0.2&#xA0;mm, pinpoint<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Indole production (tryptophanase)<hr/></td>
              <td align="center" valign="bottom">-<hr/></td>
              <td align="center" valign="bottom">-<hr/></td>
              <td align="center" valign="bottom">+<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Glucose fermentation<hr/></td>
              <td align="center" valign="bottom">NA<hr/></td>
              <td align="center" valign="bottom">+ (weak)<hr/></td>
              <td align="center" valign="bottom">+<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Utilization of:<hr/></td>
              <td align="center" valign="bottom">&#xA0;<hr/></td>
              <td align="center" valign="bottom">&#xA0;<hr/></td>
              <td align="center" valign="bottom">&#xA0;<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">&#x2003;&#x2009;Mannose<hr/></td>
              <td align="center" valign="bottom">-<hr/></td>
              <td align="center" valign="bottom">-<hr/></td>
              <td align="center" valign="bottom">+<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">&#x2003;&#x2009;Mannitol<hr/></td>
              <td align="center" valign="bottom">+<hr/></td>
              <td align="center" valign="bottom">+<hr/></td>
              <td align="center" valign="bottom">-<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">&#x2003;&#x2009;Citrate<hr/></td>
              <td align="center" valign="bottom">+<hr/></td>
              <td align="center" valign="bottom">+<hr/></td>
              <td align="center" valign="bottom">-<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">&#x2003;&#x2009;Oxidase<hr/></td>
              <td align="center" valign="bottom">+<hr/></td>
              <td align="center" valign="bottom">+<hr/></td>
              <td align="center" valign="bottom">-<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">&#x2003;&#x2009;Catalase<hr/></td>
              <td align="center" valign="bottom">-<hr/></td>
              <td align="center" valign="bottom">+ (weak)<hr/></td>
              <td align="center" valign="bottom">+<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Antimicrobial susceptibility (MIC,&#x200A;&#x3BC;g/mL)<hr/></td>
              <td align="center" valign="bottom">&#xA0;<hr/></td>
              <td align="center" valign="bottom">&#xA0;<hr/></td>
              <td align="center" valign="bottom">&#xA0;<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">&#x2003;&#x2009;Amikacin<hr/></td>
              <td align="center" valign="bottom">&gt;32<hr/></td>
              <td align="center" valign="bottom">16, S<hr/></td>
              <td align="center" valign="bottom">3, S<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">&#x2003;&#x2009;Cefepime<hr/></td>
              <td align="center" valign="bottom">NA<hr/></td>
              <td align="center" valign="bottom">&gt;32, R<hr/></td>
              <td align="center" valign="bottom">2, S<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">&#x2003;&#x2009;Ceftriaxone<hr/></td>
              <td align="center" valign="bottom">NA<hr/></td>
              <td align="center" valign="bottom">&gt;32, R<hr/></td>
              <td align="center" valign="bottom">&gt;32, R<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">&#x2003;&#x2009;Ciprofloxacin<hr/></td>
              <td align="center" valign="bottom">&lt;1<hr/></td>
              <td align="center" valign="bottom">0.003, S<hr/></td>
              <td align="center" valign="bottom">0.006, S<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">&#x2003;&#x2009;Imipenem<hr/></td>
              <td align="center" valign="bottom">2<hr/></td>
              <td align="center" valign="bottom">6.0, S<hr/></td>
              <td align="center" valign="bottom">1.0, S<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">&#x2003;&#x2009;Penicillin<hr/></td>
              <td align="center" valign="bottom">NA<hr/></td>
              <td align="center" valign="bottom">&gt;32, R<hr/></td>
              <td align="center" valign="bottom">&gt;32, R<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">&#x2003;&#x2009;Piperacillin/tazobactam<hr/></td>
              <td align="center" valign="bottom">NA<hr/></td>
              <td align="center" valign="bottom">&gt;256, R<hr/></td>
              <td align="center" valign="bottom">3, S<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">&#x2003;&#x2009;Ticarcillin/clavulanate<hr/></td>
              <td align="center" valign="bottom">NA<hr/></td>
              <td align="center" valign="bottom">&gt;256, R<hr/></td>
              <td align="center" valign="bottom">32, I<hr/></td>
            </tr>
            <tr>
              <td align="left">&#x2003;&#x2009;Trimethoprim/sulfamethoxazole</td>
              <td align="center">NA</td>
              <td align="center">0.094, S</td>
              <td align="center">0.094, S</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <p><italic>MIC</italic> minimum inhibitory concentration, <italic>NA</italic> not assessed.</p>
        </table-wrap-foot>
      </table-wrap>
      <p>In the present report, the patient was found to have necrotizing fasciitis on day 6 based on his clinical presentation. In terms of antibiotic therapy for necrotizing fasciitis, currently acceptable regimens include the admin-istration of a carbapenem or &#x3B2;-lactam/&#x3B2;-lactamase inhibitor, together with clindamycin, in addition to an agent with activity against methicillin-resistant <italic>S. aureus</italic>[<xref ref-type="bibr" rid="B6">6</xref>]. In addition, the Gram stain showed the bacteria to be gram-negative. Hence, without the results of the blood culture taken on day 4, we would likely have concluded that the infection was caused by <italic>Burkholderia</italic> spp., <italic>Aeromonas</italic> spp., or <italic>Pseudomonas</italic> spp. [<xref ref-type="bibr" rid="B7">7</xref>], and would have administrated antibiotics according to the therapy for general necrotizing fasciitis. However, <italic>C. haemolyticum</italic> has been found to be extremely resistant to beta-lactams. Therefore, as our initial findings suggested an infection with either <italic>C. haemolyticum</italic> or the closely related <italic>C. violaceum</italic>, we provided long-term ciprofloxacin. According to a study by Aldridge <italic>et al</italic>., ciprofloxacin was the most active drug in combatting <italic>C. violaceum</italic>[<xref ref-type="bibr" rid="B8">8</xref>], and several studies have reported successful treatment with this therapy.</p>
      <p>The most common symptoms of <italic>C. violaceum</italic> infections are fever and pain over the infected site, in association with various skin lesions [<xref ref-type="bibr" rid="B9">9</xref>]. To our knowledge, only 1 case of necrotizing fasciitis involving <italic>C. violaceum</italic> has been reported [<xref ref-type="bibr" rid="B10">10</xref>]. According to the pathology results, the patient in the current report had necrotizing fasciitis. Chattopadhyay <italic>et al.</italic> have recommended aggressive debridement for cases of <italic>C. violaceum</italic> infection [<xref ref-type="bibr" rid="B11">11</xref>].</p>
    </sec>
    <sec sec-type="conclusions">
      <title>Conclusions</title>
      <p><italic>C. haemolyticum</italic> should be considered in the differential diagnosis of skin lesions that progressively worsen after trauma involving exposure to river or lake water, even in temperate regions. Second, early blood cultures for isolation and identification are important for initiating proper antimicrobial therapy.</p>
      <sec>
        <title>Consent</title>
        <p>Written informed consent was obtained from the patient for publication of this case report and the accompanying images. A copy of the written consent is available for review by the Editor of this journal.</p>
      </sec>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The authors declare that they have no competing interests.</p>
    </sec>
    <sec>
      <title>Authors&#x2019; contributions</title>
      <p>MO, KS, YO, MN, TI, and AM contributed to patient management. MN and CK performed the microbiological culturing and identification. MO and RI drafted the initial manuscript. YO, MN, TI, and AM contributed to writing the report. KS, SN, and NY critically reviewed the manuscript. All the authors have provided written consent for publication. All authors read and approved the final manuscript.</p>
    </sec>
    <sec>
      <title>Pre-publication history</title>
      <p>The pre-publication history for this paper can be accessed here:</p>
      <p>
        <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2334/13/406/prepub">http://www.biomedcentral.com/1471-2334/13/406/prepub</ext-link>
      </p>
    </sec>
  </body>
  <back>
    <sec>
      <title>Acknowledgement</title>
      <p>We would like to acknowledge Takako Sakamaki and Toshiko Ooishi for their assistance, and Katsuhiko Hashimoto, Itaru Saito, Fumihito Ito, Yoshibumi Kumada, and Hideyuki Yokoyama for their assistance with patient management.</p>
    </sec>
    <ref-list>
      <ref id="B1">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Lima-Bittencourt</surname>
            <given-names>CI</given-names>
          </name>
          <name>
            <surname>Costa</surname>
            <given-names>PS</given-names>
          </name>
          <name>
            <surname>Barbosa</surname>
            <given-names>FA</given-names>
          </name>
          <name>
            <surname>Chartone-Souza</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Nascimento</surname>
            <given-names>AM</given-names>
          </name>
          <article-title>Characterization of a <italic>Chromobacterium haemolyticum</italic> population from a natural tropical lake</article-title>
          <source>Lett Appl Microbiol</source>
          <year>2011</year>
          <volume>52</volume>
          <fpage>642</fpage>
          <lpage>650</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1472-765X.2011.03052.x</pub-id>
          <pub-id pub-id-type="pmid">21466570</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Soby</surname>
            <given-names>SD</given-names>
          </name>
          <name>
            <surname>Gadagkar</surname>
            <given-names>SR</given-names>
          </name>
          <name>
            <surname>Contreras</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Caruso</surname>
            <given-names>FL</given-names>
          </name>
          <article-title><italic>Chromobacterium vaccinii</italic> sp. nov. isolated from native and cultivated cranberry (<italic>Vaccinium macrocarpon</italic> Ait.) bogs and irrigation ponds</article-title>
          <source>Int J Syst Evol Microbiol</source>
          <year>2012</year>
          <volume>63</volume>
          <fpage>1840</fpage>
          <lpage>1846</lpage>
          <pub-id pub-id-type="pmid">22984138</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Yang</surname>
            <given-names>CH</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>YH</given-names>
          </name>
          <article-title><italic>Chromobacterium violaceum</italic> infection: a clinical review of an important but neglected infection</article-title>
          <source>J Chin Med Assoc</source>
          <year>2011</year>
          <volume>74</volume>
          <fpage>435</fpage>
          <lpage>441</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jcma.2011.08.013</pub-id>
          <pub-id pub-id-type="pmid">22036134</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Sultan</surname>
            <given-names>HY</given-names>
          </name>
          <name>
            <surname>Boyle</surname>
            <given-names>AA</given-names>
          </name>
          <name>
            <surname>Sheppard</surname>
            <given-names>N</given-names>
          </name>
          <article-title>Necrotising fasciitis</article-title>
          <source>BMJ</source>
          <year>2012</year>
          <volume>345</volume>
          <fpage>e4274</fpage>
          <pub-id pub-id-type="doi">10.1136/bmj.e4274</pub-id>
          <pub-id pub-id-type="pmid">22822005</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Han</surname>
            <given-names>XY</given-names>
          </name>
          <name>
            <surname>Han</surname>
            <given-names>FS</given-names>
          </name>
          <name>
            <surname>Segal</surname>
            <given-names>J</given-names>
          </name>
          <article-title><italic>Chromobacterium haemolyticum</italic> sp. nov., a strongly haemolytic species</article-title>
          <source>Int J Syst Evol Microbiol</source>
          <year>2008</year>
          <volume>58</volume>
          <fpage>1398</fpage>
          <lpage>1403</lpage>
          <pub-id pub-id-type="doi">10.1099/ijs.0.64681-0</pub-id>
          <pub-id pub-id-type="pmid">18523185</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="book">
          <name>
            <surname>Mandell</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Bennett</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Dolin</surname>
            <given-names>R</given-names>
          </name>
          <source>Mandell, Douglas, and Bennett&#x2019;s Principles and Practice of Infectious Diseases, 7th Edition</source>
          <year>2010</year>
          <publisher-name>Philadelphia: Churchill Livingston</publisher-name>
        </mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Campbell</surname>
            <given-names>JI</given-names>
          </name>
          <name>
            <surname>Lan</surname>
            <given-names>NP</given-names>
          </name>
          <name>
            <surname>Qui</surname>
            <given-names>PT</given-names>
          </name>
          <name>
            <surname>Dung</surname>
            <given-names>LT</given-names>
          </name>
          <name>
            <surname>Farrar</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Baker</surname>
            <given-names>S</given-names>
          </name>
          <article-title>A successful antimicrobial regime for <italic>Chromobacterium violaceum</italic> induced bacteremia</article-title>
          <source>BMC Infect Dis</source>
          <year>2013</year>
          <volume>13</volume>
          <fpage>4</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-2334-13-4</pub-id>
          <pub-id pub-id-type="pmid">23286235</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Aldridge</surname>
            <given-names>KE</given-names>
          </name>
          <name>
            <surname>Valainis</surname>
            <given-names>GT</given-names>
          </name>
          <name>
            <surname>Sanders</surname>
            <given-names>CV</given-names>
          </name>
          <article-title>Comparison of the in vitro activity of ciprofloxacin and 24 other antimicrobial agents against clinical strains of <italic>Chromobacterium violaceum</italic></article-title>
          <source>Diagn Microbiol Infect Dis</source>
          <year>1988</year>
          <volume>10</volume>
          <fpage>31</fpage>
          <lpage>39</lpage>
          <pub-id pub-id-type="doi">10.1016/0732-8893(88)90124-1</pub-id>
          <pub-id pub-id-type="pmid">3168426</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal">
          <name>
            <surname>De Siqueira</surname>
            <given-names>IC</given-names>
          </name>
          <name>
            <surname>Dias</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ruf</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Ramos</surname>
            <given-names>EA</given-names>
          </name>
          <name>
            <surname>Maciel</surname>
            <given-names>EA</given-names>
          </name>
          <name>
            <surname>Rolim</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Labur</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Vasconcelos</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Silvany</surname>
            <given-names>C</given-names>
          </name>
          <article-title><italic>Chromobacterium violaceum</italic> in siblings, Brazil</article-title>
          <source>Emerg Infect Dis</source>
          <year>2005</year>
          <volume>11</volume>
          <fpage>1443</fpage>
          <lpage>1445</lpage>
          <pub-id pub-id-type="doi">10.3201/eid1109.050278</pub-id>
          <pub-id pub-id-type="pmid">16229777</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Seigel</surname>
            <given-names>JK</given-names>
          </name>
          <name>
            <surname>Stadler</surname>
            <given-names>ME</given-names>
          </name>
          <name>
            <surname>Lombrano</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Almony</surname>
            <given-names>JS</given-names>
          </name>
          <name>
            <surname>Couch</surname>
            <given-names>ME</given-names>
          </name>
          <name>
            <surname>Belhorn</surname>
            <given-names>TH</given-names>
          </name>
          <article-title><italic>Chromobacterium violaceum</italic> necrotizing fasciitis: A case report and review of the literature</article-title>
          <source>Ear Nose Throat J</source>
          <year>2012</year>
          <volume>91</volume>
          <fpage>479</fpage>
          <lpage>483</lpage>
          <pub-id pub-id-type="pmid">23288793</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Chattopadhyay</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kumar</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Bhat</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Rao</surname>
            <given-names>P</given-names>
          </name>
          <article-title><italic>Chromobacterium violaceum</italic> infection: A rare but frequently fatal disease</article-title>
          <source>J Pediatr Surg</source>
          <year>2002</year>
          <volume>37</volume>
          <fpage>108</fpage>
          <lpage>110</lpage>
          <pub-id pub-id-type="doi">10.1053/jpsu.2002.29439</pub-id>
          <pub-id pub-id-type="pmid">11781998</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
